Delivery Order SPE2DB22D3016-SPE2DB26FABT6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of CABENUVA ER 600 MG-900 MG suspension in 6 mL quantities, valued at $38,169.00 under a firm fixed-price arrangement. This non-competitive set-aside delivery order will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of October 20, 2025. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension in 6 mL quantities, valued at $3,816.90. This is a firm fixed price delivery order with an ultimate completion date of July 14, 2025, and represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $34,352.10 to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL), a long-acting injectable antiretroviral medication used in HIV treatment. This firm fixed-price delivery order, issued on June 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 through December 2026. The contract carries...
- This delivery order, valued at $22,901.40, was awarded on August 7, 2025, by the Medical Supply Chain division of the Defense Logistics Agency to AmerisourceBergen Drug Corp for the supply of Cabenuva ER 600 mg-900 mg suspension (6 mL). The award represents a firm fixed-price, non-competitive delivery order with an ultimate completion date of August 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from...
- The Defense Logistics Agency awarded a $3,914.73 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561345632 CABENUVA ER 600 MG-900 MG SUSP 6ML. Amerisourcebergen Drug Corporation will perform as the prime contractor, with corporate oversight provided by its parent company Amerisourcebergen Corporation. Work will be conducted out of Amerisourcebergen's Conshohocken, Pennsylvania location and must be completed between June 26, 2023 and July 18, 2023. No...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,917.73 on July 28, 2025, for the supply of DOVATO 50-300 mg tablets (30-count packages). This competitive award, issued without set-aside designation, carries a firm fixed price structure and an ultimate completion date of July 29, 2025. The award was made by the Defense Logistics Agency's Medical Supply Chain, a defense agency responsible for...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $32,331.16 on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price contract was issued by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on September 25, 2025, for $37,329.65 to supply Dovato 50-300 mg tablets (30-count packages). This competitively awarded, firm fixed-price delivery order is funded through the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by September 26, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $25,585.02 delivery order by the Defense Logistics Agency on November 7, 2025, for VYVGART 400 mg/20 ml vials. The contract represents a firm fixed price delivery order with an ultimate completion date of December 2, 2025, and was competitively awarded without set-aside designation. This award is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $20,568.85 to AmerisourceBergen Drug Corp on November 5, 2025, for pharmaceutical products and medical supplies. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB26FABT6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $38,169.00 to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG Suspension 6ML on November 7, 2025, with completion targeted for December 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply arrangement with DLA. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award is part of AmerisourceBergen's extensive federal pharmaceutical supply portfolio with the Defense Logistics Agency, leveraging the company's Indefinite Delivery Contract valued at $999,999,999.00 through December 2026. The contract vehicle supports military healthcare systems and other federal medical programs with comprehensive pharmaceutical products and medical supplies across multiple therapeutic domains. AmerisourceBergen's demonstrated capability in fulfilling federal medical procurement requirements through open competition, combined with its status as a critical vendor for military and veteran healthcare systems, positions the company as a key provider within DLA's Medical Supply Chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.2k | 11/7/25 |